Copyright
©The Author(s) 2017.
World J Clin Oncol. Jun 10, 2017; 8(3): 255-260
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.255
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.255
Figure 1 Pancreatic ductal adenocarcinoma with overexpression of carcinoembryonic antigen.
The neoplastic cells demonstrate strong cytoplasmic and membranous staining (100 ×). Courtesy, Department of Pathology, Temple University Hospital, Philadelphia, PA, United States.
Figure 2 Benign pancreatic ducts and acini with weak staining of the ductal cells for carcinoembryonic antigen (200 ×).
Courtesy, Department of Pathology, Temple University Hospital, Philadelphia, PA, United States.
Figure 3 Pancreatic ductal adenocarcinoma with overexpression of cancer antigen 19-9.
The neoplastic cells demonstrate strong cytoplasmic staining (100 ×). Courtesy, Department of Pathology, Temple University Hospital, Philadelphia, PA, United States.
Figure 4 Benign pancreatic ducts and acini with weak staining of the ductal cells for cancer antigen 19-9 (200 ×).
Courtesy, Department of Pathology, Temple University Hospital, Philadelphia, PA, United States.
- Citation: Agrawal S. Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma. World J Clin Oncol 2017; 8(3): 255-260
- URL: https://www.wjgnet.com/2218-4333/full/v8/i3/255.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i3.255